/ Active, not recruiting临床4期 A Prospective, Multicenter, Single-arm, Open-label, Interventional Phase IV Study to Evaluate the Safety and Efficacy of Idursulfase (r-DNA origin) (Elaprase™) in Indian Pediatric and Adult Population with Hunter Syndrome (Mucopolysaccharidosis II) - Nil
100 项与 Shire Biotech India Pvt Ltd. 相关的临床结果
0 项与 Shire Biotech India Pvt Ltd. 相关的专利(医药)
100 项与 Shire Biotech India Pvt Ltd. 相关的药物交易
100 项与 Shire Biotech India Pvt Ltd. 相关的转化医学